Trial Profile
A phase II/III trial of gastroretentive, sustained release zinc-monocysteine in patients with amyotrophic lateral sclerosis.
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 02 Dec 2011
Price :
$35
*
At a glance
- Drugs Zinc monocysteine (Primary) ; Riluzole
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 02 Dec 2011 New trial record